Home › Trial NCT01657604
TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study
- Trial IDNCT01657604
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorUniversity of Jena
- Enrollment717
- Start date2012-08-24
- ConditionsChronic Myeloid Leukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.